Analysis of risk factors for medication-overuse headache relapse: a clinic-based study in China

被引:7
|
作者
Yan, Zhihui [1 ,2 ]
Chen, Yuan [1 ]
Chen, Chunfu [1 ]
Li, Congcong [1 ]
Diao, Xiaojun [1 ]
机构
[1] Shandong Univ, Prov Hosp, Dept Neurol, Jinan 250021, Shandong, Peoples R China
[2] Yantaishan Hosp, Dept Neurol, Yantai 264001, Shandong, Peoples R China
关键词
Medication-overuse headache; Relapse; Risk factors; Non-conditional multivariate stepwise logistic regression; MIGRAINE; FEATURES;
D O I
10.1186/s12883-015-0422-1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Medication overuse headache (MOH) is the third most prevalent headache type after migraine and tension-type headache. A large number of studies on the long-term prognosis have shown that MOH has a high relapse rate after treatment. Although MOH relapse-related risk factors have been reported, no related research has been performed in China. Therefore, the purpose of this study was to analyze and evaluate the risk factors for MOH relapse in China. Methods: Eighty-six out-patients of Shandong Provincial Hospital who were initially diagnosed with MOH, and who had successful withdrawal treatment within 2 months, were chosen from March 2012 to July 2013. All subjects were followed up by the investigators of this study. Of the 86 subjects, 27 who had relapsed were compared with 59 who had not relapsed (i.e. the controls). Based on a standardized questionnaire, a database was created (with Microsoft Excel 2010). The data, which included 38 indexes, were analyzed by univariate analysis with chi-square test, Fisher's exact test, t-test, or paired rank test. The statistically correlated (P < 0.05) variables were chosen as the independent variables, thereby enabling the calculation of the non-conditional multivariate stepwise logistic regression. Results: The independent risk factors for medication-overuse headache relapse were determined as headache frequency before drug withdrawal, duration of primary headache, and headache frequency after drug withdrawal. Conclusion: Headache frequency before drug withdrawal, duration of primary headache, and headache frequency after drug withdrawal may be the independent risk factors for MOH relapse in China.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Proteomic analysis of urine in medication-overuse headache patients: possible relation with renal damages
    Elisa Bellei
    Aurora Cuoghi
    Emanuela Monari
    Stefania Bergamini
    Luca Isaia Fantoni
    Maurizio Zappaterra
    Simona Guerzoni
    Annalisa Bazzocchi
    Aldo Tomasi
    Luigi Alberto Pini
    The Journal of Headache and Pain, 2012, 13 : 45 - 52
  • [42] Medication overuse headache: rates and predictors for relapse in a 4-year prospective study
    Katsarava, Z
    Muessig, M
    Dzagnidze, A
    Fritsche, G
    Diener, HC
    Limmroth, V
    CEPHALALGIA, 2005, 25 (01) : 12 - 15
  • [43] Network meta-analysis comparing efficacy of different strategies on medication-overuse headache
    Koonalintip, Prut
    Yamutai, Suppakorn
    Setthawatcharawanich, Suwanna
    Thongseiratch, Therdpong
    Chichareon, Ply
    Wakerley, Benjamin R.
    JOURNAL OF HEADACHE AND PAIN, 2025, 26 (01)
  • [44] Detoxification in medication-overuse headache, a retrospective controlled follow-up study: Does care by a headache nurse lead to cure?
    Pijpers, J. A.
    Louter, M. A.
    de Bruin, M. E.
    van Zwet, E. W.
    Zitman, F. G.
    Ferrari, M. D.
    Terwindt, G. M.
    CEPHALALGIA, 2016, 36 (02) : 122 - 130
  • [45] Effect of prednisolone for the treatment of medication-overuse headache: A 3-month result from a multicenter REgistry for Load and management of mEdicAtion overuSE headache (RELEASE) study
    Lee, Mi Ji
    Park, Hong-Kyun
    Oh, Sun-Young
    Kang, Jin-Ju
    Hong, Yooha
    Moon, Heui-Soo
    Song, Tae-Jin
    Chu, Min Kyung
    Cho, Soo-Jin
    HEADACHE, 2024, 64 (02): : 149 - 155
  • [46] Risk factors for medication-overuse headache: An 11-year follow-up study. The Nord-Trondelag Health Studies
    Hagen, Knut
    Linde, Mattias
    Steiner, Timothy J.
    Stovner, Lars Jacob
    Zwart, John-Anker
    PAIN, 2012, 153 (01) : 56 - 61
  • [47] Pilot Study of Amitriptyline in the Prophylactic Treatment of Medication-Overuse Headache: A 1-Year Follow-Up
    Fan, Wen
    Lv, Yuhua
    Ying, Guomin
    Li, Wangwen
    Zhou, Jiying
    PAIN MEDICINE, 2014, 15 (10) : 1803 - 1810
  • [48] Questionnaire-based survey on the prevalence of medication-overuse headache in Japanese one city-Itoigawa study
    Katsuki, Masahito
    Yamagishi, Chinami
    Matsumori, Yasuhiko
    Koh, Akihito
    Kawamura, Shin
    Kashiwagi, Kenta
    Kito, Tomohiro
    Entani, Akio
    Yamamoto, Toshiko
    Ikeda, Takashi
    Yamagishi, Fuminori
    NEUROLOGICAL SCIENCES, 2022, 43 (06) : 3811 - 3822
  • [49] Factors associated with a negative outcome of medication-overuse headache: A 3-year follow-up (the 'CARE' protocol)
    Sances, Grazia
    Galli, Federica
    Ghiotto, Natascia
    Allena, Marta
    Guaschino, Elena
    Frustaci, Alessandra
    Nappi, Giuseppe
    Tassorelli, Cristina
    CEPHALALGIA, 2013, 33 (07) : 431 - 443
  • [50] Excessive iron accumulation in the striatum associated with addictive behaviors of medication-overuse headache: a prospective study
    Xun Pei
    Xiaoyan Bai
    Xue Zhang
    Zhangxuan Hu
    Wei Wang
    Xueyan Zhang
    Yingkui Zhang
    Hefei Tang
    Yaqing Zhang
    Xueying Yu
    Ziyu Yuan
    Peng Zhang
    Tong Chen
    Yuanbin Zhao
    Xiuqin Jia
    Qi Yang
    Yonggang Wang
    Binbin Sui
    BMC Medicine, 23 (1)